Dinja Kruger

MSC.

Visiting Fellow, Medical oncology

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2020

6 Article

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Sobral-Leite, M., Salomon, I., Opdam, M., Kruger, D. T., Beelen, K. J., van der Noort, V., van Vlierberghe, R. L. P., Blok, E. J., Giardiello, D., Sanders, J., van de Vijver, K., Horlings, H. M., Kuppen, P. J. K., Linn, S. C., Schmidt, M. K. & Kok, M., 2019, In : Breast Cancer Research. 21, 1, p. 90 90.

Research output: Contribution to journal › Article › Academic › peer-review

Open Access

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2- postmenopausal breast cancer patients treated with everolimus and exemestane

Kruger, D. T., Jansen, M. P. H. M., Konings, I. R. H. M., Dercksen, W. M., Jager, A., Oulad Hadj, J., Sleijfer, S., Martens, J. W. M. & Boven, E., 16 Dec 2019, In : Molecular oncology.

Research output: Contribution to journal › Article › Academic › peer-review

IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer

Kruger, D. T., Alexi, X., Opdam, M., Schuurman, K., Voorwerk, L., Sanders, J., van der Noort, V., Boven, E., Zwart, W. & Linn, S. C., 6 Sep 2019, In : International Journal of Cancer. 146, 8, p. 2348-2359

Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

Kruger, D. T., Beelen, K. J., Opdam, M., Sanders, J., van der Noort, V., Boven, E. & Linn, S. C., 2018, In : British Journal of Cancer. 119, 7, p. 832-839 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Biomarker Study Everolimus, een studie van de Borstkanker Onderzoek Groep Nederland

Kruger, D. T., Beelen, S., Sleijfer, M. P. H. M., Jansen, C. R., Jimenez, C. R., Linn, S. C. & Boven, E., 2014, In : Kanker Breed. 6, 2

Research output: Contribution to journal › Article › Popular